Deutsche Bank’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
+120,234
New +$275K ﹤0.01% 3045
2025
Q2
Sell
-96,140
Closed -$46.1K 3664
2025
Q1
$46.1K Sell
96,140
-97,228
-50% -$73K ﹤0.01% 3389
2024
Q4
$195K Buy
193,368
+173,849
+891% +$237K ﹤0.01% 3102
2024
Q3
$33.4K Buy
19,519
+12,258
+169% +$24K ﹤0.01% 3419
2024
Q2
$18.5K Sell
7,261
-2,473
-25% -$7.82K ﹤0.01% 3433
2024
Q1
$40.7K Sell
9,734
-18,757
-66% -$79.4K ﹤0.01% 3438
2023
Q4
$94.6K Buy
28,491
+27,382
+2,469% +$49.9K ﹤0.01% 3243
2023
Q3
$2.22K Sell
1,109
-22,470
-95% -$59.8K ﹤0.01% 3638
2023
Q2
$74.5K Buy
23,579
+11,119
+89% +$35.8K ﹤0.01% 3380
2023
Q1
$43.2K Buy
12,460
+5,114
+70% +$22.5K ﹤0.01% 3582
2022
Q4
$37.7K Buy
7,346
+136
+2% +$1.28K ﹤0.01% 3643
2022
Q3
$71K Sell
7,210
-1,345
-16% -$14.2K ﹤0.01% 3476
2022
Q2
$72K Sell
8,555
-1,798
-17% -$17.6K ﹤0.01% 3651
2022
Q1
$131K Buy
10,353
+3,178
+44% +$42.1K ﹤0.01% 3475
2021
Q4
$114K Buy
7,175
+380
+6% +$7.14K ﹤0.01% 3648
2021
Q3
$171K Buy
+6,795
New +$184K ﹤0.01% 3648

Other funds holding IPSC

Deutsche Bank's IPSC Position: Q2 2026 in Review

Deutsche Bank opened a new position in Century Therapeutics (IPSC) in Q2 2026: 120,234 shares worth $295K. The stake represents ﹤0.01% of the portfolio and ranks #3045 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in IPSC as recently as Q1 2025.

Deutsche Bank first reported a position in IPSC in Q3 2021 and has held it in 16 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Deutsche Bank held 120,234 shares of Century Therapeutics worth $295K as of Q2 2026.
  • Century Therapeutics was a new Deutsche Bank position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3045 holding.
  • Deutsche Bank first reported a position in Century Therapeutics in Q3 2021 and has held it in 16 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.